Učitavanje...
Prophylactic cranial irradiation in small-cell lung cancer: update on patient selection, efficacy and outcomes
Over 10% of small-cell lung cancer (SCLC) patients have brain metastases (BM) at initial diagnosis; more than 50% will develop BM within 2 years. BM are detected in up to 80% of all patients at autopsy. After primary treatment, prophylactic cranial irradiation (PCI) has been established as standard...
Spremljeno u:
| Izdano u: | Lung Cancer (Auckl) |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6181088/ https://ncbi.nlm.nih.gov/pubmed/30323698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S137577 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|